CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Low bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Low intensity of rivalry
3.3.5. Low bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in usage of animal models in virology and infectious diseases
3.4.1.2. Physiological similarity of humans and animals for drug testing
3.4.1.3. Increase in adoption of CRISPR technology
3.4.2. Restraints
3.4.2.1. Availability of alternative testing methods
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets
CHAPTER 4: ANIMAL MODEL MARKET, BY ANIMAL TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Rat
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Mice
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Guinea pigs
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Rabbits
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
4.6. Others
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market share analysis by country
CHAPTER 5: ANIMAL MODEL MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Drug discovery and development
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Basic research
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Others
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: ANIMAL MODEL MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Pharma and biotech companies
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Academic research institutes
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: ANIMAL MODEL MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Animal Type
7.2.3. Market size and forecast, by Application
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Animal Type
7.2.5.1.2. Market size and forecast, by Application
7.2.5.1.3. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Animal Type
7.2.5.2.2. Market size and forecast, by Application
7.2.5.2.3. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Animal Type
7.2.5.3.2. Market size and forecast, by Application
7.2.5.3.3. Market size and forecast, by End User
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Animal Type
7.3.3. Market size and forecast, by Application
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Animal Type
7.3.5.1.2. Market size and forecast, by Application
7.3.5.1.3. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by Animal Type
7.3.5.2.2. Market size and forecast, by Application
7.3.5.2.3. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by Animal Type
7.3.5.3.2. Market size and forecast, by Application
7.3.5.3.3. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Animal Type
7.3.5.4.2. Market size and forecast, by Application
7.3.5.4.3. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Animal Type
7.3.5.5.2. Market size and forecast, by Application
7.3.5.5.3. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Animal Type
7.3.5.6.2. Market size and forecast, by Application
7.3.5.6.3. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Animal Type
7.4.3. Market size and forecast, by Application
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by Animal Type
7.4.5.1.2. Market size and forecast, by Application
7.4.5.1.3. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by Animal Type
7.4.5.2.2. Market size and forecast, by Application
7.4.5.2.3. Market size and forecast, by End User
7.4.5.3. Australia
7.4.5.3.1. Market size and forecast, by Animal Type
7.4.5.3.2. Market size and forecast, by Application
7.4.5.3.3. Market size and forecast, by End User
7.4.5.4. India
7.4.5.4.1. Market size and forecast, by Animal Type
7.4.5.4.2. Market size and forecast, by Application
7.4.5.4.3. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Animal Type
7.4.5.5.2. Market size and forecast, by Application
7.4.5.5.3. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Animal Type
7.4.5.6.2. Market size and forecast, by Application
7.4.5.6.3. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Animal Type
7.5.3. Market size and forecast, by Application
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Animal Type
7.5.5.1.2. Market size and forecast, by Application
7.5.5.1.3. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Market size and forecast, by Animal Type
7.5.5.2.2. Market size and forecast, by Application
7.5.5.2.3. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Market size and forecast, by Animal Type
7.5.5.3.2. Market size and forecast, by Application
7.5.5.3.3. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Market size and forecast, by Animal Type
7.5.5.4.2. Market size and forecast, by Application
7.5.5.4.3. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Charles River Laboratories
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. Inotiv, Inc.
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.3. Genoway S.A.
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Key strategic moves and developments
9.4. Hera Biolabs
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.5. Crown Bioscience Inc.
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.6. Ozgene Pty Ltd.
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.7. Taconic Biosciences
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Key strategic moves and developments
9.8. The Jackson Laboratory.
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.9. Trans Genic Inc.
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.10. Janvier Labs, LLC
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
TABLE 01. GLOBAL ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
TABLE 02. ANIMAL MODEL MARKET FOR RAT, BY REGION, 2022-2032 ($MILLION)
TABLE 03. ANIMAL MODEL MARKET FOR MICE, BY REGION, 2022-2032 ($MILLION)
TABLE 04. ANIMAL MODEL MARKET FOR GUINEA PIGS, BY REGION, 2022-2032 ($MILLION)
TABLE 05. ANIMAL MODEL MARKET FOR RABBITS, BY REGION, 2022-2032 ($MILLION)
TABLE 06. ANIMAL MODEL MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 07. GLOBAL ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 08. ANIMAL MODEL MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2022-2032 ($MILLION)
TABLE 09. ANIMAL MODEL MARKET FOR BASIC RESEARCH, BY REGION, 2022-2032 ($MILLION)
TABLE 10. ANIMAL MODEL MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 11. GLOBAL ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 12. ANIMAL MODEL MARKET FOR PHARMA AND BIOTECH COMPANIES, BY REGION, 2022-2032 ($MILLION)
TABLE 13. ANIMAL MODEL MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2022-2032 ($MILLION)
TABLE 14. ANIMAL MODEL MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 15. ANIMAL MODEL MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 16. NORTH AMERICA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
TABLE 17. NORTH AMERICA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 18. NORTH AMERICA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 19. NORTH AMERICA ANIMAL MODEL MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 20. U.S. ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
TABLE 21. U.S. ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 22. U.S. ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 23. CANADA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
TABLE 24. CANADA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 25. CANADA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 26. MEXICO ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
TABLE 27. MEXICO ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 28. MEXICO ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 29. EUROPE ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
TABLE 30. EUROPE ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 31. EUROPE ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 32. EUROPE ANIMAL MODEL MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 33. GERMANY ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
TABLE 34. GERMANY ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 35. GERMANY ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 36. FRANCE ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
TABLE 37. FRANCE ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 38. FRANCE ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 39. UK ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
TABLE 40. UK ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 41. UK ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 42. ITALY ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
TABLE 43. ITALY ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 44. ITALY ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 45. SPAIN ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
TABLE 46. SPAIN ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 47. SPAIN ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 48. REST OF EUROPE ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
TABLE 49. REST OF EUROPE ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 50. REST OF EUROPE ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 51. ASIA-PACIFIC ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
TABLE 52. ASIA-PACIFIC ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 53. ASIA-PACIFIC ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 54. ASIA-PACIFIC ANIMAL MODEL MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 55. JAPAN ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
TABLE 56. JAPAN ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 57. JAPAN ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 58. CHINA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
TABLE 59. CHINA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 60. CHINA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 61. AUSTRALIA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
TABLE 62. AUSTRALIA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 63. AUSTRALIA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 64. INDIA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
TABLE 65. INDIA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 66. INDIA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 67. SOUTH KOREA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
TABLE 68. SOUTH KOREA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 69. SOUTH KOREA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 73. LAMEA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
TABLE 74. LAMEA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 75. LAMEA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 76. LAMEA ANIMAL MODEL MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 77. BRAZIL ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
TABLE 78. BRAZIL ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 79. BRAZIL ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 80. SAUDI ARABIA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
TABLE 81. SAUDI ARABIA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 82. SAUDI ARABIA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 83. SOUTH AFRICA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
TABLE 84. SOUTH AFRICA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 85. SOUTH AFRICA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 86. REST OF LAMEA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
TABLE 87. REST OF LAMEA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 88. REST OF LAMEA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 89. CHARLES RIVER LABORATORIES: KEY EXECUTIVES
TABLE 90. CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT
TABLE 91. CHARLES RIVER LABORATORIES: PRODUCT SEGMENTS
TABLE 92. CHARLES RIVER LABORATORIES: SERVICE SEGMENTS
TABLE 93. CHARLES RIVER LABORATORIES: PRODUCT PORTFOLIO
TABLE 94. CHARLES RIVER LABORATORIES: KEY STRATERGIES
TABLE 95. INOTIV, INC.: KEY EXECUTIVES
TABLE 96. INOTIV, INC.: COMPANY SNAPSHOT
TABLE 97. INOTIV, INC.: PRODUCT SEGMENTS
TABLE 98. INOTIV, INC.: PRODUCT PORTFOLIO
TABLE 99. GENOWAY S.A.: KEY EXECUTIVES
TABLE 100. GENOWAY S.A.: COMPANY SNAPSHOT
TABLE 101. GENOWAY S.A.: PRODUCT SEGMENTS
TABLE 102. GENOWAY S.A.: PRODUCT PORTFOLIO
TABLE 103. GENOWAY S.A.: KEY STRATERGIES
TABLE 104. HERA BIOLABS: KEY EXECUTIVES
TABLE 105. HERA BIOLABS: COMPANY SNAPSHOT
TABLE 106. HERA BIOLABS: PRODUCT SEGMENTS
TABLE 107. HERA BIOLABS: SERVICE SEGMENTS
TABLE 108. HERA BIOLABS: PRODUCT PORTFOLIO
TABLE 109. CROWN BIOSCIENCE INC.: KEY EXECUTIVES
TABLE 110. CROWN BIOSCIENCE INC.: COMPANY SNAPSHOT
TABLE 111. CROWN BIOSCIENCE INC.: PRODUCT SEGMENTS
TABLE 112. CROWN BIOSCIENCE INC.: SERVICE SEGMENTS
TABLE 113. CROWN BIOSCIENCE INC.: PRODUCT PORTFOLIO
TABLE 114. OZGENE PTY LTD.: KEY EXECUTIVES
TABLE 115. OZGENE PTY LTD.: COMPANY SNAPSHOT
TABLE 116. OZGENE PTY LTD.: PRODUCT SEGMENTS
TABLE 117. OZGENE PTY LTD.: SERVICE SEGMENTS
TABLE 118. OZGENE PTY LTD.: PRODUCT PORTFOLIO
TABLE 119. TACONIC BIOSCIENCES: KEY EXECUTIVES
TABLE 120. TACONIC BIOSCIENCES: COMPANY SNAPSHOT
TABLE 121. TACONIC BIOSCIENCES: PRODUCT SEGMENTS
TABLE 122. TACONIC BIOSCIENCES: PRODUCT PORTFOLIO
TABLE 123. TACONIC BIOSCIENCES: KEY STRATERGIES
TABLE 124. THE JACKSON LABORATORY.: KEY EXECUTIVES
TABLE 125. THE JACKSON LABORATORY.: COMPANY SNAPSHOT
TABLE 126. THE JACKSON LABORATORY.: PRODUCT SEGMENTS
TABLE 127. THE JACKSON LABORATORY.: PRODUCT PORTFOLIO
TABLE 128. TRANS GENIC INC.: KEY EXECUTIVES
TABLE 129. TRANS GENIC INC.: COMPANY SNAPSHOT
TABLE 130. TRANS GENIC INC.: PRODUCT SEGMENTS
TABLE 131. TRANS GENIC INC.: PRODUCT PORTFOLIO
TABLE 132. JANVIER LABS, LLC: KEY EXECUTIVES
TABLE 133. JANVIER LABS, LLC: COMPANY SNAPSHOT
TABLE 134. JANVIER LABS, LLC: PRODUCT SEGMENTS
TABLE 135. JANVIER LABS, LLC: PRODUCT PORTFOLIO
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/